Mira Pharmaceuticals Inc

Research Mira Pharmaceuticals Inc (MIRA) on Bullrun: market cap USD 39.90M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMIRA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-General
• CurrencyUSD
• Market capUSD 39.90M
• Financial periodFY2025
• Net income-USD 10.44M

Valuation Snapshot

latest market cap is USD 39.90M.

About Mira Pharmaceuticals Inc

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial.

Frequently asked questions

What is Mira Pharmaceuticals Inc's market cap?

Mira Pharmaceuticals Inc's market capitalization is USD 39.90M.

What does Mira Pharmaceuticals Inc do?

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.